Clinical Trial Update: Impact of Semaglutide on CD34+ EPC and Fat Derived MSC [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating the effect of semaglutide on CD34+ endothelial progenitor cells and fat-derived mesenchymal stem cells in adults with Type 2 d…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• semaglutide (semaglutide)

Snippet

Sponsor: Sabyasachi Sen | Conditions: Diabetes Mellitus, Type 2 | Phase 4 | Status: COMPLETED | Results posted: 2025-09-09